Article metrics

Download PDFPDF
Extended report
Nintedanib inhibits macrophage activation and ameliorates vascular and fibrotic manifestations in the Fra2 mouse model of systemic sclerosis

 

Online download statistics by month:

Online download statistics by month: August 2017 to May 2024

AbstractFullPdf
Aug 20178278583
Sep 2017648141105
Oct 20171143167127
Nov 20174709367
Dec 20172674837
Jan 20183156351
Feb 20182784546
Mar 20182496235
Apr 20182314628
May 20183635531
Jun 20182194533
Jul 20181552732
Aug 20181443325
Sep 20181913721
Oct 20181253930
Nov 20181854020
Dec 20181482825
Jan 2019922311
Feb 20191664231
Mar 20191302212
Apr 20191444330
May 20192945741
Jun 20191243329
Jul 20191613221
Aug 20192083717
Sep 20192213213
Oct 20191904225
Nov 20192225041
Dec 20192544231
Jan 20201805339
Feb 20202416539
Mar 20202674526
Apr 20201113320
May 20201794523
Jun 20201212520
Jul 20201512220
Aug 20201802218
Sep 20201692923
Oct 20202484932
Nov 20201541912
Dec 20201642223
Jan 20211993318
Feb 20212212119
Mar 20212832422
Apr 20211372827
May 2021923647
Jun 2021473622
Jul 2021352820
Aug 2021302318
Sep 2021341811
Oct 2021136147
Nov 20213283618
Dec 20211592614
Jan 20221653430
Feb 20222212319
Mar 20221512310
Apr 2022268197
May 20222852925
Jun 20222462613
Jul 2022137156
Aug 2022168199
Sep 20222151913
Oct 2022170249
Nov 2022180123
Dec 20221561511
Jan 2023142247
Feb 2023242278
Mar 2023122242
Apr 20231401910
May 20231811912
Jun 2023146164
Jul 2023137121
Aug 2023187124
Sep 2023151205
Oct 2023160249
Nov 20231761812
Dec 20232021712
Jan 2024185167
Feb 2024250169
Mar 2024182136
Apr 20241821510
May 2024140144
Total1731728251913